NCT06048770View on ClinicalTrials.gov

A Study of RBI-4000 in Healthy Participants

PHASE1TerminatedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

RBI-4000

RBI-4000 intramuscular injection.

BIOLOGICAL

RabAvert

RabAvert intramuscular injection.

Trial Locations (2)

33155

Cordova Research Institute, Miami

68134

Velocity Clinical Research, Omaha

Sponsors
All Listed Sponsors
lead

Replicate Bioscience

INDUSTRY

NCT06048770 - A Study of RBI-4000 in Healthy Participants | Biotech Hunter | Biotech Hunter